HFM
AGIO icon

Harvest Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

Harvest Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-600
Closed -$33K – 758
2021
Q2 		$33K Buy
+600
New +$33.6K ﹤0.01% 533
2018
Q3 		– Sell
-777
Closed -$65K – 423
2018
Q2 		$65K Buy
+777
New +$67.8K 0.01% 158

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Harvest Fund Management's AGIO Position: Q3 2021 in Review

Harvest Fund Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 600 shares — an estimated $33K sold.

Harvest Fund Management first reported a position in AGIO in Q2 2018 and held it in 2 quarters. The position peaked at $65K in Q2 2018. 165 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Harvest Fund Management reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Harvest Fund Management sold 600 Agios Pharmaceuticals shares in Q3 2021, an estimated $33K.
  • Harvest Fund Management first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Harvest Fund Management's Agios Pharmaceuticals position peaked at $65K in Q2 2018.
  • 165 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Harvest Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.